COVID-19, Is Hydroxychloroquine The Treatment For Coronavirus?


Is Hydroxychloroquine The Treatment For Coronavirus? 

 India biggest producer of 'game-changer' hydroxychloroquine drug ...

In the past, hydroxychloroquine (HCQ) has been making news again. US President Donald Trump has once again promoted the use of this drug as a cure for the Coronavirus, or COVID-19. The US has also reached out to India to lift the ban on hydroxychloroquine exports, which India had imposed on March 26. It is not just Trump and the US who want India to lift restrictions on exports of what is believed to be the miracle drug to cure Coronavirus. Brazilian President Jair Bolsonaro, among other state leaders, is also believed to have reached out to the Indian authorities in an attempt to have the ban overturned. In fact, the Government of India has already placed an order of 10 crore tablets with Ipca laboratories and Zydus Cadila.
What is Chloroquine? 
Chloroquine phosphate is a class of drugs called antimalarials and amebicides and is used to prevent and treat malaria, according to the US National Library of Medicine.
They add that Chloroquine phosphate is used occasionally to decrease the symptoms of rheumatoid arthritis and to treat systemic and discoid lupus erythematosus, scleroderma, pemphigus, lichen planus, polymyositis, sarcoidosis, and porphyria cutanea tarda.
Governments believe that hydroxychloroquine tablets can work as a prophylactic, a medicine that prevents disease, for the health workers working on the frontlines in hospitals and as first responders to possible Coronavirus infection cases.

Uses
Hydroxychloroquine is used to prevent or treat malaria caused by mosquito bites.
The United States Center for Disease Control provides updated guidelines and travel recommendations for the prevention and treatment of malaria in different parts of the world.
Discuss the most recent information with your doctor before traveling to areas where malaria occurs.
This medication is also used to treat certain auto-immune diseases (lupusrheumatoid arthritis).
It belongs to a class of medications known as disease-modifying antirheumatic drugs (DMARDs). It can reduce skin problems in lupus and prevent swelling/pain in arthritis.

What experts say on the use of hydroxychloroquine for Covid-19 patients
Top US infectious disease expert Dr Anthony Fauci, in an interview with CNN said,"I would have two words for you: 'second opinion.' Hydroxychloroquine is officially approved for treating malaria, rheumatoid arthritis and lupus, but not Covid-19."
Fauci said more testing is needed before it's clear that the drug works against the coronavirus and is safe for COVID-19 patients. Health experts also warn the drugs’ well-known side effects could become commonplace with wide use.
In particular, they say, patients with existing heart problems or taking certain drugs, such as anti-depressants that affect heart rhythm, are at risk of a fatal episode.
Experts recommend screening before the drugs are prescribed to prevent drug-related deaths.

Demand for hydroxychloroquine
Hydroxychloroquine is an inexpensive and easily available drug. However, its demand has risen dramatically ever since it was named as a possible treatment for Covid-19. India manufactures it in large quantities.
The government banned the export of the drug "without any exception". The order came even as the number of positive cases of Covid-19 spiked in the country.
However, the government partially lifted the ban, paving the way for its supply to the US and several other countries hit hard by the coronavirus pandemic.
Government officials said India would export hydroxychloroquine and paracetamol on a case-by-case basis to the countries which have already placed orders for them after meeting the domestic requirements.
The decision to partially lift the ban on hydroxychloroquine came to the fore hours after US President Donald Trump warned of retaliation if India does not heed to his request to supply the drug, cited by him as a viable therapeutic solution to fight coronavirus infection.

Post a Comment

0 Comments